Yongjian Guo
250 East Changgang Rd
Guangzhou, 510260, China
Guangzhou, 510260, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
HSP90α-USP7-DNMT1 Axis Drives Hepatocellular Carcinoma Recurrence After Microwave Ablation by Disrupting ACSS3-Mediated Propionate Metabolism.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 13, 2026
Exploratory investigation of dose calculation and tumor-feeding artery identification using dual CBCT in selective internal radiation therapy with Yttrium-90 microspheres.
Journal: Frontiers in oncology
Published: June 28, 2025
SIRT or TACE in combination with Lenvatinib and PD-(L)1 inhibitor in high tumor burden hepatocellular carcinoma: a multicenter, retrospective, propensity score-matched study.
Journal: International journal of surgery (London, England)
Published: June 03, 2025
Sorafenib Combined with Tislelizumab and Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: A Phase II Study.
Journal: ImmunoTargets and therapy
Published: May 30, 2025
Screening the advantageous population for liver cancer undergoing yttrium-90 microsphere selective internal radiation therapy.
Journal: Liver research (Beijing, China)
Published: November 02, 2024
Acid-responsive engineered bacteria with aberrant In-Situ anti-PD-1 expression for post-ablation immunotherapy of hepatocellular carcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 06, 2024
Lenvatinib plus drug-eluting bead transarterial chemoembolization with/without hepatic arterial infusion chemotherapy for hepatocellular carcinoma larger than 7 cm with major portal vein tumor thrombosis: a multicenter retrospective cohort study.
Journal: International journal of surgery (London, England)
Published: February 26, 2024
Microbial-derived Urolithin A Targets GLS1 to Inhibit Glutaminolysis and Attenuate Cirrhotic Portal Hypertension.
Journal: Cellular and molecular gastroenterology and hepatology
Published: December 22, 2023
Intratumoral Lactate Depletion Based on Injectable Nanoparticles-Hydrogel Composite System Synergizes with Immunotherapy against Postablative Hepatocellular Carcinoma Recurrence.
Journal: Advanced healthcare materials
Published: September 11, 2023
Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II study.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: September 10, 2023
Tyrosine-kinase inhibitor combined with iodine-125 seed brachytherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: a propensity-matched study.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: March 29, 2023
Last Updated: 09/26/2026